Webinars

Our webinars bring together leading clinicians, researchers, and support specialists to help you better understand myeloma and its treatment.

Stay informed with expert‑led education.

Our webinars share practical, reliable information from leading myeloma specialists. Each session breaks down complex topics into simple guidance you can use.

Watch live or explore past recordings to learn at your own pace.
Every webinar is designed to help you feel supported, informed, and more confident.

  • Investigating the impact of dietary interventions in progression of MGUS to SMM

    In this webinar, Dr. Urvi Shah from Memorial Sloan Kettering Cancer Center discusses the critical role of diet, the microbiome, and other modifiable lifestyle factors in managing precursor conditions to multiple myeloma, such as MGUS and Smoldering Myeloma. Learn about the latest research investigating how nutritional interventions might delay disease progression. Dr. Shah shares compelling…

    Watch now

  • Supportive care and shared decision making

    Dr Donna Kademero discusses supportive care, symptom management, CAR T-cell therapy, and bispecific antibodies in multiple myeloma, with practical guidance for patients and care teams.

    Watch now

  • The multiple myeloma shared decision making on ChoiceApp

    Introducing Choice App, a free tool to help myeloma patients identify & communicate treatment preferences for better shared decision-making with their healthcare team.

    Watch now

  • MGUS to myeloma

    Professor Huang Quach explains the journey from MGUS to myeloma, modern diagnostic criteria (SLiM CRAB), and how new immune therapies are improving survival towards an “operational cure.”

    Watch now

  • Young and strong – thriving with myeloma

    A national seminar for younger people living with myeloma, covering treatment side effects, financial planning, and adapting to changing relationships with expert clinicians and specialists.

    Watch now

  • T cell directed therapies – National myeloma month 2023

    Professor Joy Ho explains CAR T-cell therapy and bispecific antibodies in multiple myeloma, covering recent trial results, side effects, sequencing, and Australian trial progress.

    Watch now